Severe vascular complications in essential thrombocythemia (ET):: A study of the predictive factors in a series of 148 patients

被引:0
|
作者
Cervantes, F [1 ]
Besses, C [1 ]
Pereira, A [1 ]
Florensa, L [1 ]
Solé, F [1 ]
Hernández-Boluda, JC [1 ]
Woessner, S [1 ]
Sans-Sabrafén, J [1 ]
Rozman, C [1 ]
Montserrat, E [1 ]
机构
[1] Hosp Del Mar, Unitat Hematol 1973, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:310 / 310
页数:1
相关论文
共 50 条
  • [31] THROMBOTIC AND BLEEDING PROFILE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
    Yus Cebrian, F.
    de Portugal Casana, C. Coello
    Tercero-Mora Rodriguez, M.
    Fernandez Mosteirin, N.
    Caballero Navarro, G.
    Delgado Beltran, P.
    HAEMATOLOGICA, 2015, 100 : 758 - 759
  • [32] BIOMARKERS FOR PREDICTION OF THROMBOSIS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
    Podolak-Dawidziak, M.
    Prajs, I.
    Kuliczkowski, K.
    HAEMATOLOGICA, 2015, 100 : 755 - 756
  • [33] Essential thrombocythemia: Baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients
    Angona, Anna
    Alvarez-Larran, Alberto
    Bellosillo, Beatriz
    Martinez-Aviles, Luz
    Garcia-Pallarols, Francesc
    Longaron, Raquel
    Ancochea, Agueda
    Besses, Caries
    MEDICINA CLINICA, 2015, 144 (06): : 247 - 253
  • [34] Essential thrombocythemia: Analysis of risk factors for thrombotic events in a series of 306 patients.
    Radaelli, F
    Bramanti, S
    Colombi, M
    Iurlo, A
    Zanella, A
    BLOOD, 2005, 106 (11) : 314B - 314B
  • [35] A pilot study of hydroxyurea or Pipobroman in essential thrombocythemia (ET)
    Guilmin, F
    Gardin, C
    Najean, Y
    Dutel, JL
    Harousseau, JL
    Briere, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 884 - 884
  • [36] INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    CORTELAZZO, S
    VIERO, P
    FINAZZI, G
    DEMILIO, A
    RODEGHIERO, F
    BARBUI, T
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 556 - 562
  • [37] Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia
    Michiels, JJ
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1999, 5 (04) : 247 - 251
  • [38] CLINICAL DIFFERENCES IN ESSENTIAL THROMBOCYTHEMIA PATIENTS WITH AND WITHOUT THROMBOTIC COMPLICATIONS
    Zherniakova, A.
    Shuvaev, V.
    Martynkevich, I.
    Polushkina, L.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2015, 100 : 540 - 540
  • [39] Complex intracranial vascular complications caused by essential thrombocythemia: a critical case report
    Jian Xie
    Leiyu Geng
    Baoyu Yuan
    Yijing Guo
    Zhijun Zhang
    BMC Neurology, 20
  • [40] TREATMENT RESPONSE AND COMPLICATIONS OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA RECEIVING HYDROXYUREA
    Sotiropoulos, D.
    Papalexandri, A.
    Tsirigotis, P.
    Pouli, A.
    Kyriazopoulos, P.
    Protopapa, M.
    Dervenoulas, I.
    Fassas, A.
    Anagnostopoulos, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 58 - 59